1 / 49

Acute Heart Failure Chief Rounds, Sept. 14, 2009 Dr. Frederic L. Ginsberg

Acute Heart Failure Chief Rounds, Sept. 14, 2009 Dr. Frederic L. Ginsberg. CJTMEustaquio, MD PGY-3. Internal Medicine Cooper University Hospital. I. Introduction - Definition & Causes - General Approach II. Case 1: LS, 62M. cc: chest pain - Discussion: Management

jaeger
Download Presentation

Acute Heart Failure Chief Rounds, Sept. 14, 2009 Dr. Frederic L. Ginsberg

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Acute Heart FailureChief Rounds, Sept. 14, 2009Dr. Frederic L. Ginsberg CJTMEustaquio, MD PGY-3. Internal Medicine Cooper University Hospital

  2. I. Introduction - Definition & Causes - General Approach II. Case 1: LS, 62M. cc: chest pain - Discussion: Management III. Case 2: DF, 60M. cc: syncope - Discussion: Management IV. Case 3: DK, 63F. cc: dyspnea - Discussion: Management V. Conclusion

  3. I. INTRODUCTION • Potentially fatal • Key concepts • Determinants of cardiac output • Heart failure - dyspnea • Introduction • Case 1 • Case 2 • Case 3 • Conclusion "demand >> supply"

  4. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Congestive Heart Failure "volume of blood >> heart's capacity" no congestion congestion

  5. Introduction • Case 1 • Case 2 • Case 3 • Conclusion • Acute decompensated heart failure - Potentially fatal • Cardiogenic pulmonary edema • Flash pulmonary edema

  6. General Approach • Suspect the diagnosis from S/Sx - HPI: cough, SOB, fatigue, chest pain/ discomfort - PE: RR, HR,  or BP accessory muscles wheezing S3, S4 gallop murmurs  JVP pedal edema • Introduction • Case 1 • Case 2 • Case 3 • Conclusion

  7. Consider precipitating factors CARDIAC MI & myocardial ischemia Atrial fibrillation, other arrhythmias Progression of underlying cardiac dysfunction RV pacing with dyssynchrony NON CARDIAC Severe HTN Renal failure Miscellaneous: anemia hypo/hyperthyroidism toxins (cocaine, EtOH) fever & infection uncontrolled DM Medications PE Dietary indiscretion, medication noncompliance, iatrogenic volume overload • Introduction • Case 1 • Case 2 • Case 3 • Conclusion

  8. Introduction • Case 1 • Case 2 • Case 3 • Conclusion • Tests a. EKG b. CXR c. Lab data - CBC, basic chem 7, cardiac enzymes BNP, NT-proBNP Lipid profile, LFTs, TSH d. Echo e. Swan-Ganz catheter f. Coronary Angiography g. Others: EP studies • Treat

  9. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Case 1: LS, 62M. Cc: chest pain • SSCP at rest SOB, dyspnea on exertion Diaphoresis • HTN, DM, HPL CAD s/p POBA 1991 Previous smoker • Metoprolol, HCTZ, Glyburide, Enalapril, Fish Oil, Lovastatin • 95.2F, 78, 164/83, 18, 99%RA No JVD. CTA b/l. RRR, good S1/S2, no m/r/g No pedal edema.

  10. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Recommendations for the Evaluation of Patients with HF

  11. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Case 1: LS, 62M. Cc: chest pain

  12. Introduction • Case 1 • Case 2 • Case 3 • Conclusion • Diagnoses: • NSTEMI • Chronic Systolic Heart Failure 2 to severe CAD, • not in acute decompensation • HTN, DM, HPL

  13. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Recommendations for the Evaluation of Patients with HF

  14. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Recommendations for the Evaluation of Patients with HF

  15. Introduction • Case 1 • Case 2 • Case 3 • Conclusion The Stages of Heart Failure – NYHA Classification

  16. Introduction • Case 1 • Case 2 • Case 3 • Conclusion • Management: Medical + Evaluation for CABG - Thallium viability study: viable myocardium except distal apex - Discharged, then readmitted in 2 weeks for planned CABG x5: LIMA to D2 and LAD. SVG to D1. SVG to posterior descending artery & distal RCA.

  17. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Treatment Recommendations for Patients at High Risk of Developing Heart Failure (Stage A)

  18. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Treatment Recommendations for Patients with Asymptomatic LV Systolic Dysfunction (Stage B)

  19. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Treatment Recommendations for Symptomatic LV Systolic Dysfunction (Stage C)

  20. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Treatment Recommendations for Symptomatic LV Systolic Dysfunction (Stage C)

  21. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Case 2: DF, 60M. Cc: Syncope

  22. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Case 2: DF, 60M. Cc: Syncope • OSH: light headedness & syncope - (+) troponin - atrial flutter - severe hypotension – on Norepinephrine drip (Levophed) - transferred to CUH for cardiac catheterization • PMH: - Hepatitis C - s/p cholecystectomy - ESRD on HD - s/p patial colectomy 2 to polyps - NHL s/p chemo 2007 - s/p hernia repair - HTN - s/p AV fistula - ascites

  23. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Case 2: DF, 60M. Cc: Syncope • SH: current smoker – 43py occasional EtOH former IVDA, quit 1978 • PE: afebrile, 127/91, HR=98, RR=30 • JVP=15 cm H20, 2+ carotid upstrokes • CTA B/L • RR, tachycardic, normal S1/S2 • Hepatomegaly • No LE edema

  24. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Case 2: DF, 60M. Cc: Syncope

  25. Diagnoses: - Acute Decompensated Heart Failure - Syncope. - NICMP EF 10-15%. - Paroxysmal atrial flutter. - ESRD. • Introduction • Case 1 • Case 2 • Case 3 • Conclusion Case 2: DF, 60M. Cc: Syncope

  26. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Recommendations for the Management of Acute Heart Failure • Hospitalization • Hypotension, worsening renal function or altered mentation • Dyspnea at rest • Arrhythmia • ACS • In-patient monitoring • Hemodynamic monitoring • Treatment goals

  27. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Goals of Initial Management of ADHF • Hemodynamic stabilization • Support of oxygenation and ventilation • Symptom relief

  28. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Treatment Goals for Patients with ADHF • Improve symptoms • Optimize volume status • Identify etiology • Identify precipitating factors • Optimize chronic oral therapy • Minimize side effects • Identify patients who might benefit from revascularization • Educate

  29. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Components of Therapy for ADHF • Na and fluid restriction • Diuretics • Oxygen and assisted ventilation • Morphine • Vasodilator – nitrate, nesiritide • Inotropic agents – dobutamine, milrinone • ACE inhibitors and ARBs • Beta-blockers

  30. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Case 2: DF, 60M. Cc: Syncope • Medications: - ASA 325 mg daily - ISMN ER 30 mg daily - Carvedilol 25 mg BID - Hydralazine 10 mg TID - Valsartan 80 mg daily - Temazepam 30 mg daily - Gabapentin 300 mg BID - Percocet prn - Warfarin 2.5 mg daily

  31. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Additional Considerations in ADHF • Arrhythmia management • Mechanical cardiac assistance • Ultrafiltration • Vasopressin receptor antagonist

  32. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Case 2: DF, 60M. Cc: Syncope • EP studies, re atrial flutter. • TEE: no A-V clot • Atrial flutter ablation & ICD placement • Anticoagulation with Warfarin.

  33. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Case 2: DF, 60M. Cc: Syncope Why the decision for an ICD during this admission vs. waiting 3 months of max medical therapy as in Case 1?

  34. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Recommendations for Management of Concomitant Diseases in Patients with HF

  35. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Case 2: DF, 60M. Cc: Syncope What inotropes are recommended had he still been hypotensive on transfer to CUH?

  36. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Case 3: DK, 63F. Cc: dyspnea

  37. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Case 3: DK, 63F. Cc: dyspnea • Admitted under GYN in May & June 2009, cc: Nausea, vomiting • Recent ovarian CA recurrence • Developed acute, severe SOB at rest while on the floors ICU transfer & BIPAP • PMH: - Ovarian CA 1997, s/p resection 1st recurrence, 2002. s/p chemo 2nd recurrence, May 2009. - HTN – Tenormin 80 mg daily - DM II – Metformin 500 mg BID, Pioglitazone 45mg daily - sulfa allergy

  38. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Case 3: DK, 63F. Cc: dyspnea • FH: MI – father 75, brother 63 COPD – mother  64, sister • SH: no smoking, no EtOH • ROS: occasional palpitations, fatigue • PE: BP 124/55, HR 98 no JVD LLL crackles normal S1/S2, no murmurs, (+) S3 gallop no pedal edema

  39. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Case 3: DK, 63F. Cc: dyspnea

  40. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Case 3: DK, 63F. Cc: dyspnea • Diagnoses: - Acute decompensated heart failure (with cardiogenic pulmonary edema) - Cardiomyopathy with severe LV dysfunction, unclear etiology - Single vessel CAD – likely not the cause of CMP - DM II - HTN - Ovarian CA - HPL

  41. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Case 3: DK, 63F. Cc: dyspnea • Medical therapy for ADHF • (IV Furosemide, Carvedilol, Lisinopril , ASA, statin. NPPV)  symptomatic improvement  back to GYN floors, discharged after 15 days • HF meds discontinued on D/C – unclear reason • Out-patient cardiology F/U within 1 week: - SOB much improved, only mild SOB on climbing 1 flight of stairs - back on Tenormin; not on beta blocker, ASA, ACE-I - Add ASA, Carvedilol. - Repeat echo in 2 weeks. - F/U with GYN re Tx plan for ovarian CA recurrence.

  42. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Case 3: DK, 63F. Cc: dyspnea Takotsubo cardiomyopathy??

  43. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Takotsubo cardiomyopathy • Stress-induced CMP • Apical ballooning syndrome • Broken heart syndrome • Transient LV systolic dysfunction • Mimics MI • No significant CAD

  44. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Takotsubo Cardiomyopathy • Stress-induced • Acute medical illness / intense emotional stress / physical stress • Pathogenesis unknown • Catecholamine excess, coronary artery spasm, microvascular dysfunction

  45. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Takotsubo Cardiomyopathy • Treatment and prognosis • Supportive • Hydration • Standard HF meds • ACE inhibitor • Beta-blocker • Diuretic • Aspirin • MR 0 – 8 % • Recovery in 1 to 4 weeks

  46. Introduction • Case 1 • Case 2 • Case 3 • Conclusion Conclusion • Heart failure and ACS • ADHF in atrial flutter & ESRD • Takotsubo CMP • Evaluation guidelines in HF • Management principles in ADHF • Management of HF in general

More Related